Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011, Article ID 269378, 7 pages
http://dx.doi.org/10.1155/2011/269378
Research Article

Dysregulation of the Intrarenal Vitamin D Endocytic Pathway in a Nephropathy-Prone Mouse Model of Type 1 Diabetes

Arkansas Children's Hospital Research Institute, Department of Pediatrics, University of Arkansas for Medical Sciences, 1 Children's Way, Slot 512-6, Little Rock, AR 72202, USA

Received 30 December 2010; Revised 17 March 2011; Accepted 18 March 2011

Academic Editor: Daisuke Koya

Copyright © 2011 John L. Fowlkes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Jefferson, S. J. Shankland, and R. H. Pichler, “Proteinuria in diabetic kidney disease: a mechanistic viewpoint,” Kidney International, vol. 74, no. 1, pp. 22–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. H. Hryciw, E. M. Lee, C. A. Pollock, and P. Poronnik, “Molecular changes in proximal tubule function in diabetes mellitus,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 5-6, pp. 372–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Russo, R. M. Sandoval, S. B. Campos, B. A. Molitoris, W. D. Comper, and D. Brown, “Impaired tubular uptake explains albuminuria in early diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 20, no. 3, pp. 489–494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. M. Thrailkill, T. Nimmo, R. C. Bunn et al., “Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin,” Diabetes Care, vol. 32, no. 7, pp. 1266–1268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Thrailkill, C. H. Jo, G. E. Cockrell, C. S. Moreau, and J. L. Fowlkes, “Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 142–149, 2011. View at Publisher · View at Google Scholar
  6. A. Tojo, M. L. Onozato, H. Ha et al., “Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats,” Histochemistry and Cell Biology, vol. 116, no. 3, pp. 269–276, 2001. View at Google Scholar · View at Scopus
  7. A. Nykjaer, D. Dragun, D. Walther et al., “An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3,” Cell, vol. 96, no. 4, pp. 507–515, 1999. View at Google Scholar · View at Scopus
  8. Z. Qi, H. Fujita, J. Jin et al., “Characterization of susceptibility of inbred mouse strains to diabetic nephropathy,” Diabetes, vol. 54, no. 9, pp. 2628–2637, 2005. View at Publisher · View at Google Scholar
  9. K. M. Thrailkill, S. Kumar, C. K. Rosenberg, K. J. Auten, and J. L. Fowlkes, “Characterization of matrix metalloproteinases in human urine: alterations during adolescence,” Pediatric Nephrology, vol. 13, no. 3, pp. 223–229, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Fowlkes, R. C. Bunn, L. Liu et al., “Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus,” Endocrinology, vol. 149, no. 4, pp. 1697–1704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Z. Kounnas, D. A. Chappell, D. K. Strickland, and W. S. Argraves, “Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro,” Journal of Biological Chemistry, vol. 268, no. 19, pp. 14176–14181, 1993. View at Google Scholar · View at Scopus
  12. S. Amsellem, J. Gburek, G. Hamard et al., “Cubilin is essential for albumin reabsorption in the renal proximal tubule,” Journal of the American Society of Nephrology, vol. 21, no. 11, pp. 1859–1867, 2010. View at Publisher · View at Google Scholar
  13. J. G. Hoenderop, B. Nilius, and R. J. Bindels, “Calcium absorption across epithelia,” Physiological Reviews, vol. 85, no. 1, pp. 373–422, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. I. Christensen and H. Birn, “Megalin and cubilin: multifunctional endocytic receptors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 4, pp. 256–266, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Leheste, B. Rolinski, H. Vorum et al., “Megalin knockout mice as an animal model of low molecular weight proteinuria,” American Journal of Pathology, vol. 155, no. 4, pp. 1361–1370, 1999. View at Google Scholar · View at Scopus
  16. S. Kantarci, L. Al-Gazali, R. S. Hill et al., “Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes,” Nature Genetics, vol. 39, no. 8, pp. 957–959, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Guggino, “Mechanisms of disease: what can mouse models tell us about the molecular processes underlying Dent disease?” Nature Clinical Practice Nephrology, vol. 3, no. 8, pp. 449–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Zou, B. Chung, T. Nguyen, S. Mentone, B. Thomson, and D. Biemesderfer, “Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule,” Journal of Biological Chemistry, vol. 279, no. 33, pp. 34302–34310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. D. V. Rozanov, E. Hahn-Dantona, D. K. Strickland, and A. Y. Strongin, “The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells,” Journal of Biological Chemistry, vol. 279, no. 6, pp. 4260–4268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. M. Thrailkill, R. C. Bunn, C. S. Moreau et al., “Matrix metalloproteinase-2 dysregulation in type 1 diabetes,” Diabetes Care, vol. 30, no. 9, pp. 2321–2326, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. T. Ward, S. K. Yau, A. P. Mee et al., “Functional, molecular, and biochemical characterization of streptozotocin-induced diabetes,” Journal of the American Society of Nephrology, vol. 12, no. 4, pp. 779–790, 2001. View at Google Scholar · View at Scopus
  22. L. E. Schneider, H. P. Schedl, T. McCain, and M. R. Haussler, “Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat,” Science, vol. 196, no. 4297, pp. 1452–1454, 1977. View at Google Scholar · View at Scopus
  23. J. R. Leheste, F. Melsen, M. Wellner et al., “Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect,” The FASEB Journal, vol. 17, no. 2, pp. 247–249, 2003. View at Google Scholar · View at Scopus
  24. T. Maritzen, G. Rickheit, A. Schmitt, and T. J. Jentsch, “Kidney-specific upregulation of vitamin D3 target genes in ClC-5 KO mice,” Kidney International, vol. 70, no. 1, pp. 79–87, 2006. View at Publisher · View at Google Scholar
  25. V. Thongboonkerd, S. Zheng, K. R. McLeish, P. N. Epstein, and J. B. Klein, “Proteomic identification and immunolocalization of increased renal calbindin-D28k expression in OVE26 diabetic mice,” The Review of Diabetic Studies, vol. 2, no. 1, pp. 19–26, 2005. View at Google Scholar
  26. A. Verstuyf, G. Carmeliet, R. Bouillon, and C. Mathieu, “Vitamin D: a pleiotropic hormone,” Kidney International, vol. 78, no. 2, pp. 140–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes, “Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues,” American Journal of Physiology, vol. 289, no. 5, pp. E735–E745, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Zhang, D. K. Deb, J. Kong et al., “Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist,” American Journal of Physiology, vol. 297, no. 3, pp. F791–F801, 2009. View at Publisher · View at Google Scholar · View at Scopus